Table 4.
The association between serum AG and mortalities in patients stratified by serum lactate.
AG< 8 mmol/L | 8 ≤ AG ≤ 16 mmol/L | AG> 16 mmol/L | ||||
---|---|---|---|---|---|---|
OR (95% CI) | P | OR (95% CI) | P | OR (95% CI) | P | |
Serum lactate < 2 mmol/L | ||||||
ICU mortality | ||||||
Model 1 | 2.733 (1.039-7.186) | 0.042 | 1(ref) | 1.492 (1.193-1.867) | <0.001 | |
Model 2 | 2.896 (1.062-7.895) | 0.038 | 1(ref) | 1.151 (0.912-1.451) | 0.236 | |
Model 3 | 3.046 (1.117-8.304) | 0.029 | 1(ref) | 1.177 (0.926-1.497) | 0.182 | |
Hospital mortality | ||||||
Model 1 | 1.986 (0.812-4.862) | 0.133 | 1(ref) | 1.701 (1.425-2.029) | <0.001 | |
Model 2 | 2.016 (0.791-5.139) | 0.142 | 1(ref) | 1.345 (1.118-1.618) | 0.002 | |
Model 3 | 1.989 (0.782-5.063) | 0.149 | 1(ref) | 1.395 (1.153-1.686) | 0.001 | |
Serum lactate ≥ 2 mmol/L | ||||||
ICU mortality | ||||||
Model 1 | 1.991 (0.409-9.692) | 0.394 | 1(ref) | 2.382 (1.936-2.930) | <0.001 | |
Model 2 | 1.598 (0.315-8.094) | 0.571 | 1(ref) | 1.906 (1.539-2.359) | <0.001 | |
Model 3 | 1.535 (0.299-7.892) | 0.608 | 1(ref) | 1.902 (1.528-2.367) | <0.001 | |
Hospital mortality | ||||||
Model 1 | 1.274 (0.263-6.187) | 0.763 | 1(ref) | 2.393 (2.000-2.863) | <0.001 | |
Model 2 | 1.004 (0.198-5.087) | 0.997 | 1(ref) | 1.918 (1.591-2.312) | <0.001 | |
Model 3 | 0.978 (0.190-5.042) | 0.979 | 1(ref) | 1.870 (1.544-2.265) | <0.001 |
Model 1: unadjusted; model 2: adjusted for age, gender, ethnicity, and APACHE IV score; model 3: adjusted for age, gender, ethnicity, APACHE IV score, heart failure, respiratory failure, renal failure, liver diseases, coagulopathy, sepsis, trauma, shock, hypertension, and diabetes mellitus. AG, anion gap; APACHE, acute physiology and chronic health evaluation; CI, confidence interval; ICU, intensive care unit; OR, odds ratio.